Vitality Biopharma Inc Stock Other OTC
Equities
US86031Q1040
Environmental Services & Equipment
End-of-day quote
Other stock markets
|
||
- USD | - |
04-26 | Range Impact, Inc. Announces Executive Changes | CI |
04-26 | Range Impact, Inc. Announces Chief Financial Officer Changes | CI |
Sales 2022 | 4.83M 6.58M | Sales 2023 | 19.35M 26.33M | Capitalization | 27.28M 37.12M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.36M | Net income 2023 | 3M 4.08M | EV / Sales 2022 | 3.86 x |
Net Debt 2022 | 4.61M 6.28M | Net Debt 2023 | 8.23M 11.2M | EV / Sales 2023 | 1.84 x |
P/E ratio 2022 |
-11.4
x | P/E ratio 2023 |
7.17
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 18-11-14 | |
Patricia Missal
DFI | Director of Finance/CFO | 55 | 23-05-31 |
Rebecca Wharton
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Feighan
CHM | Chairman | 76 | 18-11-14 |
Chief Executive Officer | 50 | 18-11-14 | |
Richard Celeste
BRD | Director/Board Member | 86 | 19-01-23 |
1st Jan change | Capi. | |
---|---|---|
+18.40% | 83.83B | |
+13.81% | 58.88B | |
+20.25% | 24.41B | |
+31.10% | 11.62B | |
+21.05% | 11.47B | |
-6.87% | 6.36B | |
+23.97% | 4.86B | |
+22.89% | 4.78B | |
-3.12% | 3.08B |